R&D Strategies of Pharmaceutical Companies and Current Status of CRO/SMO 2024
Coverage: (Product/service)
R&D Strategies of Pharmaceutical Companies
Research Target:
Pharmaceutical Companies,CRO companies, SMO companies
Research Content:
I. R&D Strategies of Pharmaceuticals and Actual Status & Perspective of CRO/SMO
1. R&D Strategies of Pharmaceuticals
2. Actual Status & Perspective of CRO
3. Actual Status & Perspective of SMO
II. R&D Strategies of Leading Pharmaceuticals
1. Astellas Pharma Inc.
2. AstraZeneca K.K.
3. Eisai Co., Ltd.
4. Otsuka Holdings Co., Ltd.
5. ONO PHARMACEUTICAL CO., LTD.
6. Kyowa Kirin Co., Ltd.
7. Sanofi K.K.
8. Sumitomo Pharma Co., Ltd.
9. SHIONOGI & CO., LTD.
10. DAIICHI SANKYO COMPANY, LIMITED
11. Takeda Pharmaceutical Company Limited.
12. Mitsubishi Tanabe Pharma Corporation
13. CHUGAI PHARMACEUTICAL CO., LTD.
14. Eli Lilly Japan K.K.
15. Novartis Pharma K.K.
16. Bayer Yakuhin, Ltd.
III. Strategies of CRO Companies and SMO Companies
1. M3, Inc.
2. CMIC HOLDINGS Co., Ltd.
Plus, brief profiles of leading CROs (29 enterprises) and leading SMOs (22 enterprises)